| Financial Year |
March 31 2023 |
| Monetary Funds |
195,718,135.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,288,507.50 |
| Accounts Receivable |
341,791,469.18 |
| Advances to Suppliers |
27,694,522.29 |
| Other Receivables |
43,395,964.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
299,423,985.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,768,335.31 |
| Total Current Assets |
952,798,668.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
81,961,521.00 |
| Investment Properties |
-- |
| Fixed Assetes |
542,252,304.53 |
| Under-construction Projects |
109,179,777.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
129,416,317.87 |
| R&D expenses |
-- |
| Goodwill |
289,071,640.04 |
| Long-Term Deferred and Prepaid Expenses |
16,026,237.16 |
| Deferred Income Tax Assets |
15,409,572.97 |
| Other Non-Current Assets |
6,824,598.29 |
| Sub-Total of Non-Current Assets |
1,214,036,476.03 |
| Total Assets |
2,166,835,144.51 |
| Short-Term Loans |
416,965,813.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
64,299,619.35 |
| Accounts Payable |
256,853,143.34 |
| Accounts Received In Advance |
3,039,303.09 |
| Employee Compensation Payable |
32,325,039.63 |
| Taxes Payable |
31,734,100.44 |
| Interest Payable |
235,166.67 |
| Dividend Payable |
-- |
| Other payables |
21,421,313.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,962,691.66 |
| Other Current Liabilities |
4,195,337.50 |
| Sub-Total of Current Liabilities |
872,606,159.48 |
| Long-term Loans |
25,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
23,005,526.75 |
| Deferred Income Tax Liabilities |
15,812,228.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
84,268,266.05 |
| Total Liabilities |
956,874,425.53 |
| Paid-In Capital(Or Share Stock) |
338,533,715.00 |
| Capital Surplus |
530,128,559.26 |
| Surplus Reserve |
48,405,587.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
239,120,926.42 |
| Minority Stockholder's Interest |
53,771,931.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,156,188,787.94 |
| Owner's Equity（Stockholder's Equity） |
1,209,960,718.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,166,835,144.51 |
